Business Context and Reporting Period
This Form 6-K filing by Bio Blast Pharma Ltd. (also referenced as Enlivex Ltd. in metadata) covers the second quarter ended June 30, 2015. The report, dated August 21, 2015, incorporates a press release (Exhibit 99.1) announcing financial results for the period.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a cover report incorporating the press release by reference but does not list the financial data directly within the text supplied.
Material Changes
The filing text does not provide data to compare current period performance against prior comparable periods. Specific material changes in financial position or results of operations are not detailed in the provided content.
Guidance, Outlook, and Risks
The provided text does not include management commentary, forward-looking guidance, specific risk factors, contingencies, or unusual items. It strictly references the attached press release for the announcement of results.
Investor Verification Checklist
- Verify the specific financial figures (revenue, net loss, cash position) in the attached Exhibit 99.1 press release, as they are not present in this cover document.
- Confirm the company's current legal name status, as the metadata lists "Enlivex Ltd." while the filing header lists "Bio Blast Pharma Ltd."
- Review the incorporated GAAP financial statements referenced in the Form F-3 and Form S-8 registration statements for detailed historical data.
- Check for subsequent filings that may supersede the information contained in this August 2015 report.